Robert Williamson

Robert F.
Williamson is the founder of LaSalle Venture Advisers, founded in 2002.
Mr. Williamson is the founder of Aegle Therapeutics Corp., founded in 2013, serving as Chief Financial Officer & Director.
Current jobs include President, Chief Executive Officer & Director at Sidecar Therapeutics, Inc.; Director at Clarke Industrial Engineering, Inc.; President, Chief Operating Officer & Director at Triumvira Immunologics USA, Inc. since 2022; Independent Director at Perspective Therapeutics, Inc. since 2023; and Member-Coulter Oversight Board at the University of Miami.
Former jobs include Chief Executive Officer & Director at Arriva Pharmaceuticals, Inc. (2006); Acting Chief Executive Officer at BrainCells, Inc.; Chief Executive Officer at ATXCo, Inc.; Chief Executive Officer & Director at PharmAkea, Inc. (2013–2019); President, Chief Executive Officer & Director at BioTheryX, Inc. (2020–2021); Executive Chairman at Strategic Enzyme Applications, Inc. (2008–2013); Executive Chairman at HAYA Therapeutics SA (2021–2022); Independent Director at Pharmasset, Inc. (2012); Director at TBG Diagnostics Ltd. (2008–2009); Director at IsoRay, Inc.; Director at Viewpoint (US); President & Chief Operating Officer at DoubleTwist, Inc. (1999–2002); Partner at The Boston Consulting Group, Inc. (1991–1999); President & Chief Operating Officer at EOS Biotechnology, Inc. (2002–2004); Research Assistant at Federal Reserve System (1987–1989); Chief Financial Officer at Oncomyx Therapeutics, Inc. (2022).
Education includes undergraduate degree from Pomona College and MBA from Stanford University.